생명과학 BPO 시장 : 세계 산업 규모, 점유율, 동향, 기회 및 예측 - 서비스별, 지역별 세분화 및 경쟁 구도(2020-2030년)

The Global Life Sciences BPO Market, valued at USD 476.00 Billion in 2024, is projected to experience a CAGR of 9.10% to reach USD 802.72 Billion by 2030. Life Sciences Business Process Outsourcing (BPO) encompasses the strategic delegation of non-core activities by pharmaceutical, biotechnology, and medical device companies to external service providers, covering functions from research and development support to commercial operations. This market's growth is primarily driven by the imperative for cost efficiency, enabling companies to convert fixed costs into variable ones and optimize resource allocation.

Key Market Drivers

The expansion of the Global Life Sciences BPO Market is largely propelled by the critical need for cost optimization and operational efficiency across the pharmaceutical, biotechnology, and medical device sectors. Companies in these industries increasingly leverage outsourcing to transform fixed overheads into variable costs, thereby enhancing financial agility and resource allocation. This strategic shift allows organizations to streamline non-core processes, such as administrative functions and certain support operations, which directly contributes to significant savings. For instance, according to Kelly Services, in 2023, a global pharmaceutical company achieved savings exceeding $1 million in its first year by adopting a specialized BPO administrative model. This highlights the tangible financial benefits realized through externalizing specific business processes.

Key Market Challenges

The inherent risk associated with data security and the protection of intellectual property directly impedes the growth of the Global Life Sciences BPO Market. Life sciences companies operate with highly sensitive and valuable data, including proprietary research and development information, clinical trial results, and confidential patient data. Entrusting this critical information to external service providers introduces significant vulnerabilities to potential data breaches, unauthorized access, or intellectual property theft. The profound reputational damage, regulatory penalties, and competitive disadvantages that can result from such incidents make organizations hesitant to extensively outsource core functions.

Key Market Trends

The increased adoption of AI and Machine Learning transforms life sciences BPO operations. These technologies enable providers to move towards intelligent automation, predictive analytics, and enhanced decision support, facilitating solutions like AI-driven pharmacovigilance and optimized clinical trial recruitment. This improves data processing speed and accuracy for complex data sets. According to The Pistoia Alliance, 68% of life science professionals surveyed in 2024 were already utilizing AI and machine learning, an increase from 54% in 2023. This trend reflects a clear commitment to leveraging AI for operational excellence. For instance, in August 2025, Cognizant launched its TriZetto AI Gateway, integrating its healthcare ecosystem with generative AI to advance healthcare delivery efficiency.

Key Market Players

• Atos SE
• Boehringer Ingelheim International GmbH
• Catalent Inc
• Labcorp Early Development Laboratories Inc
• ICON PLC
• Infosys Ltd
• International Business Machines Corporation (IBM)
• Lonza Group AG
• PAREXEL International Corp
• IQVIA Inc

Report Scope:

In this report, the Global Life Sciences BPO Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Life Sciences BPO Market, By Services:

• Pharmaceutical outsourcing
• Medical devices outsourcing
• Contract sales & market outsourcing
• Others

Life Sciences BPO Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies presents in the Global Life Sciences BPO Market.

Available Customizations:

Global Life Sciences BPO Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Life Sciences BPO Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Services (Pharmaceutical outsourcing, Medical devices outsourcing, Contract sales & market outsourcing, Others)
  • 5.2.2. By Region
  • 5.2.3. By Company (2024)
• 5.3. Market Map

6. North America Life Sciences BPO Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Services
  • 6.2.2. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Life Sciences BPO Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Services
  • 6.3.2. Canada Life Sciences BPO Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Services
  • 6.3.3. Mexico Life Sciences BPO Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Services

7. Europe Life Sciences BPO Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Services
  • 7.2.2. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Life Sciences BPO Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Services
  • 7.3.2. France Life Sciences BPO Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Services
  • 7.3.3. United Kingdom Life Sciences BPO Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Services
  • 7.3.4. Italy Life Sciences BPO Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Services
  • 7.3.5. Spain Life Sciences BPO Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Services

8. Asia Pacific Life Sciences BPO Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Services
  • 8.2.2. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Life Sciences BPO Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Services
  • 8.3.2. India Life Sciences BPO Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Services
  • 8.3.3. Japan Life Sciences BPO Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Services
  • 8.3.4. South Korea Life Sciences BPO Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Services
  • 8.3.5. Australia Life Sciences BPO Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Services

9. Middle East & Africa Life Sciences BPO Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Services
  • 9.2.2. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Life Sciences BPO Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Services
  • 9.3.2. UAE Life Sciences BPO Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Services
  • 9.3.3. South Africa Life Sciences BPO Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Services

10. South America Life Sciences BPO Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Services
  • 10.2.2. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Life Sciences BPO Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Services
  • 10.3.2. Colombia Life Sciences BPO Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Services
  • 10.3.3. Argentina Life Sciences BPO Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Services

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Life Sciences BPO Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Atos SE
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boehringer Ingelheim International GmbH
• 15.3. Catalent Inc
• 15.4. Labcorp Early Development Laboratories Inc
• 15.5. ICON PLC
• 15.6. Infosys Ltd
• 15.7. International Business Machines Corporation (IBM)
• 15.8. Lonza Group AG
• 15.9. PAREXEL International Corp
• 15.10. IQVIA Inc

16. Strategic Recommendations

17. About Us & Disclaimer